Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma, Breast”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT03057743
What this trial is testing

Imaging of in Vivo Sigma-2 Receptor Expression With 18F-ISO-1 Positron Emission Tomography in Metastatic Breast Cancer

Who this might be right for
METASTATIC BREAST CANCER
Abramson Cancer Center at Penn Medicine 4
Not applicableNot Yet RecruitingNCT06902935
What this trial is testing

Establishment and Clinical Application of Breast Cancer Risk Prediction Model Based on Traditional Chinese Medicine Four Diagnostic Instruments and Ultrasound

Who this might be right for
Breast Cancer Screening
Taizhou Hospital 1,500
Testing effectiveness (Phase 2)WithdrawnNCT04265274
What this trial is testing

Vinorelbine, Cisplatin, Disulfiram and Copper in CTC_EMT Positive Refractory Metastatic Breast Cancer.

Who this might be right for
Metastatic Breast Cancer
National Cancer Institute, Slovakia
Testing effectiveness (Phase 2)Study completedNCT00258960
What this trial is testing

Caelyx, Cyclophosphamide and Herceptin in Patients With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Spanish Breast Cancer Research Group 49
Not applicableLooking for participantsNCT06991946
What this trial is testing

Patient-Centric Study to Assess the Impact of Genomic Profiling on the Treatment of Patients With Metastatic Breast Cancer in Spain

Who this might be right for
Metastatic Breast Cancer
SOLTI Breast Cancer Research Group 300
Not applicableWithdrawnNCT01960803
What this trial is testing

Lumpectomy Followed By Intraoperative Electron Radiation Therapy (IOERT)

Who this might be right for
Invasive Ductal Breast CancerCarcinoma Breast Stage I
Wake Forest University Health Sciences
Not applicableNot Yet RecruitingNCT06920108
What this trial is testing

TRACE4BUS for BI-RADS Classification

Who this might be right for
Breast Cancer
DeepTrace Technologies S.r.l. 590
Testing effectiveness (Phase 2)WithdrawnNCT03644589
What this trial is testing

Effect of Pembrolizumab and Cisplatin on Metastatic, Locally Recurrent or Inoperable Triple-Negative Breast Cancer

Who this might be right for
Estrogen Receptor NegativeHER2/Neu NegativeMetastatic Breast Cancer+3 more
University of Washington
Not applicableStudy completedNCT03998618
What this trial is testing

Telephone Support for Metastatic Breast Cancer Patients

Who this might be right for
Metastatic Breast Cancer
Indiana University 250
Not applicableStudy completedNCT06470490
What this trial is testing

Effect of Psycho-Educational Program and Relaxation Training on Resilience Among Women With Breast Cancer

Who this might be right for
Women With Breast Cancer
Abeer Abd Elwahed Almowafy 100
Not applicableStudy completedNCT05022823
What this trial is testing

Exercise and Compression for Lymphedema

Who this might be right for
Breast Cancer Related Lymphedema
AHS Cancer Control Alberta 40
Not applicableStudy completedNCT07223476
What this trial is testing

Treatment Landscape and Real-World Dosing Patterns With CDK4/6 Inhibitors for Breast Cancer in Portugal

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 1,926
Early research (Phase 1)Ended earlyNCT03685591
What this trial is testing

PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors

Who this might be right for
Breast NeoplasmsProstate NeoplasmsNeoplasms, Squamous Cell+6 more
Pfizer 49
Not applicableNot Yet RecruitingNCT07670182
What this trial is testing

The Efficacy of Combined Peripheral Blood CTCs and Serum HER2 Detection in Docetaxel-based Treatment for HER2 Low-expression Breast Cancer

Who this might be right for
Patients With Low HER2 Expression (IHC 1+ or IHC 2+/ISH-) and HER2 IHC 0 Advanced Breast Cancer
Tianjin Medical University Cancer Institute and Hospital 100
Testing effectiveness (Phase 2)Study completedNCT00303524
What this trial is testing

Comparative Study of Oestradiol Suppression: Zoladex 10.8mg/3 Month vs. 3.6mg/Month in ER +ve EBC Pre-menopausal Patients

Who this might be right for
Breast Cancer
AstraZeneca 170
Not applicableLooking for participantsNCT07729423
What this trial is testing

Mepitel Film Breast

Who this might be right for
Breast CancerRadiation Dermatitis
National University Hospital, Singapore 60
Large-scale testing (Phase 3)Study completedNCT03726879
What this trial is testing

Evaluate the Efficacy and Safety Of Atezolizumab or Placebo in Combination With Neoadjuvant Doxorubicin + Cyclophosphamide Followed By Paclitaxel + Trastuzumab + Pertuzumab In Early Her2-Positive Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 454
Large-scale testing (Phase 3)Study completedNCT01104935
What this trial is testing

National Surgical Adjuvant Study of Breast Cancer(N-SAS BC) 07 [RESPECT]

Who this might be right for
Breast Cancer
Comprehensive Support Project for Oncology Research 275
Not applicableStudy completedNCT04394325
What this trial is testing

Digi-Do - a Digital Information Tool to Help Patients Diagnosed With Breast Cancer

Who this might be right for
Breast Cancer
Jonkoping University 80
Large-scale testing (Phase 3)Study completedNCT00329940
What this trial is testing

Safety and Rheumatologic Tolerability of Letrozole in Postmenopausal Patients With Hormone Receptor Positive Breast Cancer

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 200
Next Page